Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randy Strong

Showing results (41-50 of 97) with videos related to

Pageof 10
Sort By:
Endocrinology|May 14, 2010
Early postnatal administration of growth hormone increases tuberoinfundibular dopaminergic neuron numbers in Ames dwarf miceChristina E Khodr, Sara Clark, Alex F Bokov, et al.
Plos One|April 9, 2010
Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's diseasePatricia Spilman, Natalia Podlutskaya, Matthew J Hart, et al.
Biochemical and Biophysical Research Communications|June 11, 2002
Cloning and characterization of a testis and brain-specific isoform of mouse 3'-phosphoinositide-dependent protein kinase-1, mPDK-1 betaLily Q Dong, Fresnida J Ramos, Michael J Wick, et al.
Research Square|February 12, 2024
Development of primary osteoarthritis during aging in genetically diverse UM-HET3 miceSher Bahadur Poudel, Ryan R Ruff, Gozde Yildirim, et al.
Pathobiology of Aging & Age Related Diseases|August 27, 2015
Rapamycin improves motor function, reduces 4-hydroxynonenal adducted protein in brain, and attenuates synaptic injury in a mouse model of synucleinopathyXiang Bai, Margaret Chia-Ying Wey, Elizabeth Fernandez, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
Development of primary osteoarthritis during aging in genetically diverse UM-HET3 miceSher Bahadur Poudel, Ryan R Ruff, Gozde Yildirim, et al.
Arthritis Research & Therapy|June 8, 2024
Development of primary osteoarthritis during aging in genetically diverse UM-HET3 miceSher Bahadur Poudel, Ryan R Ruff, Gozde Yildirim, et al.
Aging Cell|January 4, 2012
Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1β and enhancing NMDA signalingSmita Majumder, Antonella Caccamo, David X Medina, et al.
Aging|October 18, 2014
Rapamycin-induced metabolic defects are reversible in both lean and obese miceYuhong Liu, Vivian Diaz, Elizabeth Fernandez, et al.
Brain and Behavior|July 15, 2023
Impaired aldehyde detoxification exacerbates motor deficits in an alpha-synuclein mouse model of Parkinson's diseasePaul Anthony Martinez, Vanessa Elia Martinez, Sheela Rani, et al.
Pageof 10

Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
Endocrinology|May 14, 2010
Early postnatal administration of growth hormone increases tuberoinfundibular dopaminergic neuron numbers in Ames dwarf miceChristina E Khodr, Sara Clark, Alex F Bokov, et al.
Plos One|April 9, 2010
Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's diseasePatricia Spilman, Natalia Podlutskaya, Matthew J Hart, et al.
Biochemical and Biophysical Research Communications|June 11, 2002
Cloning and characterization of a testis and brain-specific isoform of mouse 3'-phosphoinositide-dependent protein kinase-1, mPDK-1 betaLily Q Dong, Fresnida J Ramos, Michael J Wick, et al.
Research Square|February 12, 2024
Development of primary osteoarthritis during aging in genetically diverse UM-HET3 miceSher Bahadur Poudel, Ryan R Ruff, Gozde Yildirim, et al.
Pathobiology of Aging & Age Related Diseases|August 27, 2015
Rapamycin improves motor function, reduces 4-hydroxynonenal adducted protein in brain, and attenuates synaptic injury in a mouse model of synucleinopathyXiang Bai, Margaret Chia-Ying Wey, Elizabeth Fernandez, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
Development of primary osteoarthritis during aging in genetically diverse UM-HET3 miceSher Bahadur Poudel, Ryan R Ruff, Gozde Yildirim, et al.
Arthritis Research & Therapy|June 8, 2024
Development of primary osteoarthritis during aging in genetically diverse UM-HET3 miceSher Bahadur Poudel, Ryan R Ruff, Gozde Yildirim, et al.
Aging Cell|January 4, 2012
Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1β and enhancing NMDA signalingSmita Majumder, Antonella Caccamo, David X Medina, et al.
Aging|October 18, 2014
Rapamycin-induced metabolic defects are reversible in both lean and obese miceYuhong Liu, Vivian Diaz, Elizabeth Fernandez, et al.
Brain and Behavior|July 15, 2023
Impaired aldehyde detoxification exacerbates motor deficits in an alpha-synuclein mouse model of Parkinson's diseasePaul Anthony Martinez, Vanessa Elia Martinez, Sheela Rani, et al.
Pageof 10